Research
In silico screening of FDA-approved drugs for elimination of senescent cells via senescence-associated anti-apoptotic pathway inhibition
Nature ·
The Brief
- The study is an in silico screen of FDA-approved drugs.
- It aims to find drugs that eliminate senescent cells.
- The approach works by inhibiting senescence-associated anti-apoptotic pathways.
Why it matters
It proposes a computational route to repurpose approved drugs as senolytics, which could speed up testing of candidates that target senescent cells. The source provides only the title, so the results are not known.
Who’s affected
- researchers studying cellular senescence and aging
- drug repurposing and computational pharmacology researchers
- #senescence
- #senolytics
- #drug repurposing
- #in silico screening
- #apoptosis